Maternal Baicalin Treatment Increases Fetal Lung Surfactant in Rats
Author Information
Author(s): Chen Chung-Ming, Wang Leng-Fang, Cheng Kur-Ta
Primary Institution: Taipei Medical University
Hypothesis
Maternal baicalin treatment might increase fetal lung surfactant production in vivo in preterm rats.
Conclusion
Maternal baicalin treatment increases pulmonary surfactant phospholipids in fetal rat lungs, which may accelerate lung maturation.
Supporting Evidence
- Maternal treatment with 2-day baicalin significantly increased saturated phospholipid in fetal lung tissue compared to control.
- Two-day baicalin-treated fetuses had significantly higher total phospholipid than control and 1-day baicalin groups.
- Antenatal treatment with 2-day baicalin significantly increased maternal growth hormone compared to control.
Takeaway
Giving a special medicine called baicalin to pregnant rats helps their babies' lungs grow better and produce more important substances for breathing.
Methodology
Timed pregnant Sprague-Dawley rats were injected with baicalin or control solution, and fetal lung tissue was analyzed for phospholipid content.
Limitations
The study was conducted on a small number of rats and may not fully represent human outcomes.
Participant Demographics
Timed pregnant Sprague-Dawley rats.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website